Project CARE: CAncer Risk Evaluation
Anita Y. Kinney, PhD, RN · NCT07130487
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–70 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 210
- US sites recruiting
- 1
- Study start
- November 19, 2025
- Record last updated
- November 25, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of Project CARE (cancer risk assessment and evaluation) research study is to explore the acceptance and feasibility of a study-initiated proactive outreach and digital care delivery model for conducting hereditary cancer risk assessment in primary care settings and facilitating genetic risk evaluation for patients flagged as high risk. Potential participants will be recruited from Rutgers Health primary care sites (family practice and general internal medicine). EPIC will be used to identify all potential participants and they will be invited to participate in the study. Consented participants will be provided a link via email, and or text message to engage with a Relational Agent (RA, chatbot), through the patient portal for cancer risk assessment and genetic education. Those identified as high risk will be offered genetic counseling and testing.
The research questions the study aims to answer are:
- What percent of patients who completed the RA are identified as high risk?
- What percent of patients who engaged with the risk assessment were identified as high risk?
- What percent of high-risk patients had genetic counseling or genetic testing within 4 months of completing the risk assessment?
Being studied: Relational Agent ( RA) Alex
Conditions: Primary Care
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Age 18 to 70 years
- Able to read and speak English
- Have an email address or mobile phone number in EPIC and/or are enrolled in MyChart
- Receiving health care in Family Medicine or General Internal Medicine at Rutgers Health within the past 2 years
- Have not opted out of receiving research-related communications
- Have internet access (via smartphone, tablet, or computer)
Exclusion Criteria
- Dementia (e.g., Alzheimer's disease) as indicated in EPIC
- Unable to access the Internet (via smartphone, tablet, or computer)
- Previous germline genetic testing for hereditary cancer risk
- Opted out of research participation in EPIC
- Have a personal history of cancer
Recruiting US locations
Rutgers, The State University of New Jersey
New Brunswick, NJ 08901
Site contact: Julie Chapman-Greene, PhD, MPH · 732-865-3375 · chapmaje@cinj.rutgers.edu
Study contacts (from the official record)
- Julie Chapman-Greene, PhD, MPH · 732-865-3375 · chapmaje@cinj.rutgers.edu
- Emily Heidt, MPH · 732-235-8930 · ekh47@cinj.rutgers.edu
Similar studies in New Jersey
All healthy volunteers studies in New Jersey →- RecruitingHealthy volunteersPhase 1
Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
Arcutis Biotherapeutics, Inc.
- Location
- Fair Lawn, NJ + 6 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Clinical Trial of MK-1406 in Healthy Participants (MK-1406-008)
Merck Sharp & Dohme LLC
- Location
- Marlton, NJ + 5 other US sites
- Eligibility basics
- Ages 18–64
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Jersey City, NJ + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
Study of Single Doses of HBS-104 in Acutely Sleep-deprived Healthy Participants
Harmony Biosciences Management, Inc.
- Location
- Eatontown, NJ
- Eligibility basics
- Ages 18–55